However, in the last 15 years different approaches have shown that optimization of different parameters contributes to enhanced transfection and hence immunogenicity of DNA vaccines also in human. these parameters, and combination treatment with additional drugs. PSI-7977 [221] or attenuated ([222] and [223]) bacterial strains are often used as vectors, termed bactofection [224]. In the intestine, these bacteria may be phagocytosed directly by mucosal DC/macrophages spreading extensions into the gut lumen or after M cell-mediated transcytosis at the Peyers patches [225]. After phagocytosis, plasmid DNA is usually released from phagolysosome, and the numerous bacteria-associated danger signals result in profound APC activation [226]. More recently, bacterial ghosts which constitute only the bacterial envelope have been introduced as carriers for DNA vaccines [227]. Aside oral application, bacteria were shown to confer transfection of APC when applied at other mucosal sites, e.g., when applied intranasally [228]. More recently, the DNA vaccine delivery properties of orally applied bacteria, for example with regard to phagolysosomal escape have been improved by additional coating with NC [229]. Compared with other sytemic routes of DNA vaccination, pulmonary application of aerolized DNA vaccines is usually a rather new approach [230]. Usage of naked and NC-complexed DNA was demonstrated to yield transfection of lung epithelial cells [231]. Hence, so far research focusses on therapeutic treatment of local gene defects as in case of cystic fibrosis [232]. The skin constitutes an interesting target organ for DNA vaccination due to the rather high frequency of cutaneous DC. For example, human skin, depending on the specific site, contains 200C1000 LC per square millimeter [233]. Furthermore, in skin (activated) DC are the only cell populations showing migratory behavior towards draining lymph nodes to evoke T cell responses [234]. Different transdermakl DNA vaccination strategies have been developed, and their suitability is usually clinically tested [235]. Needle-free biolistic transfection as mediated by gene gun [69] and PMED (particle-mediated epidermal delivery [236] devices transfers microparticle-adsorbed DNA into the epidermal layer by helium pressure to transfect LC, dermal DC (and keratinocytes). Of note, the physical stress associated with biolistic transfection, was reported as sufficient to mediate activation and emigration of directly transfected DC [237]. Microneedles which are produced from various materials and techniques display lenghts below one micron [238] and tattooing devices [239] address these cell types as well. Conventional intradermal administration of DNA vaccines by syringes aims to transfect dermal DC (and fibroblasts). Based on the observation that after intradermal injection of DNA a short electrical pulse, termed electroporation, mediates several-fold enhanced transfection has resulted in the development of a number of according devices tested in clinical studies [240]. Similarly, in vaccination studies transfection rates of myocytes after intramuscular injection of DNA, intended to generate antigen for uptake by APC, were found strongly elevated by electroporation as well [106]. In general, electroporation in the context of transdermal [241] and intramuscular [242] DNA vaccination was reported to result in local activation of innate immunity which may be a consequence of e.g., electroporation-induced cellular stress reactions, including necrosis. Concerning the success of immunization of different DNA vaccination routes, the recent phase I trial CUTHIVEC which assessed in a comparative manner the efficacy of different PSI-7977 DNA vaccine administration routes showed increased antigen specific CD4+ and CD8+ responses after combined intramuscular and transcutaneous injection compared to intramuscular plus intradermal injections [43]. The former approach was even more efficient than intramuscular administration followed by electroporation (EP) at the PSI-7977 injection PSI-7977 side. EP is frequently used to increase the overall transfection efficiency at the injection site and was shown to efficiently enhance immune responses in rhesus macaques after DNA vaccination [243]. In general, the application method itself beyond mediating APC activation may also influence T cell polarization. In a comparative study, intramuscular DNA vaccination resulted in a Th1-biased T cell response (see above), whereas biolistic transfection yielded a Th2 response [244]. With regard to the distribution of DNA vaccines complexed with NC it is noteworthy that small particles are easily transported into the lymph node, while larger particles remain longer at the site of administration [245]. In addition, the route of administration can KMT2C also account for the fate of the delivery systems. After subcutaneous injection small PEGylated liposomes were found in larger amount in the lymph node than after intravenous or intraperitoneal injection [246]. Concerning NC clearance from the body, NC that are smaller than 8 nm are cleared renally [247], and the extent of renal clearance was shown to correlate with the extent of unfavorable charge [248]. Biliary clearance was.